InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
51%
T+90 mean return
-0.5%
Across 39 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ullem Scott B., Chief Financial Officer. Officer active across 3 companies, notably Edwards Lifesciences Corp. In total, 57 disclosures have been recorded. History available since 4 May 2021. The latest transaction was filed on 11 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations57 total
19,830 shares0Common StockSEC:0001225208-26-005133
19,830 shares0Common StockSEC:0001225208-26-005133:0
3,780 shares0Common StockSEC:0001127602-25-015500:0
1,070 shares@ US$83.6243.1% of flowCommon StockSEC:0001127602-25-015019:0
1,200 shares@ US$73.680.9% of flowCommon StockSEC:0001225208-25-004996:0
1,406 shares@ US$74.921.1% of flowCommon StockSEC:0001225208-25-004942:0
635 shares@ US$75.650.5% of flowCommon StockSEC:0001225208-25-004765:0
229 shares@ US$104.921812.0% of flowCommon StockSEC:0001127602-25-010802:0
11,250 shares@ US$45.27675.4% of flowCommon StockSEC:0001225208-25-003654:0
11,250 shares@ US$45.27675.6% of flowCommon StockSEC:0001225208-25-002619:0
174 shares@ US$76.190.1% of flowCommon StockSEC:0001225208-25-001908:0
11,250 shares@ US$45.27675.6% of flowCommon StockSEC:0001225208-25-001712:0
158 shares@ US$142.063911.6% of flowCommon StockSEC:0001127602-25-000136:0
11,250 shares@ US$45.27675.5% of flowCommon StockSEC:0001225208-24-010647:0
183 shares@ US$122.779310.9% of flowCommon StockSEC:0001127602-24-024722:0
205 shares@ US$109.653811.3% of flowCommon StockSEC:0001127602-24-019543:0
5,625 shares@ US$45.27672.7% of flowCommon StockSEC:0001225208-24-006925:0
5,625 shares@ US$45.27672.7% of flowCommon StockSEC:0001225208-24-006287:0
2,622 shares0Common StockSEC:0001127602-24-015920:0
1,198 shares@ US$86.721.1% of flowCommon StockSEC:0001225208-24-005978:0
11,075 shares0Common StockSEC:0001225208-24-005885:0
634 shares@ US$85.060.6% of flowCommon StockSEC:0001225208-24-005707:0
7,250 shares@ US$36.752.9% of flowCommon StockSEC:0001225208-24-005397:0
163 shares@ US$137.68211.2% of flowCommon StockSEC:0001127602-24-011920:0
7,255 shares@ US$36.752.8% of flowCommon StockSEC:0001225208-24-004692:0
25 of 57 declarations
About Ullem Scott B.
Scott B. Ullem is the Chief Financial Officer at Edwards Lifesciences Corp. He is responsible for the financial management of the company, including financial planning, risk management, and financial strategy. With deep expertise in the field, he plays a crucial role in optimizing financial performance and making informed decisions to support the company's growth.
